Evaluation of Efficacy of Denosumab in Patients With Thalassemia Major and Osteoporosis: A Randomized, Placebo-controlled, Single-site, Double Blind Phase 2b Clinical Trial
Phase of Trial: Phase II
Latest Information Update: 28 Aug 2019
Price : $35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 31 Oct 2018 According to a Blood Advances media release, results from this study were published online today in the journal Blood Advances.
- 31 Oct 2018 Results presented in a Blood Advances media release.
- 10 Mar 2017 Status changed from active, no longer recruiting to completed.